ID

36640

Description

Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance; ODM derived from: https://clinicaltrials.gov/show/NCT01191099

Lien

https://clinicaltrials.gov/show/NCT01191099

Mots-clés

Versions (2)
  1. 17/01/2019 17/01/2019 -
  2. 27/05/2019 27/05/2019 -
Détendeur de droits

University of Zurich

Téléchargé le

27 mai 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Hypoxia in Prostate Cancer NCT01191099

Anglais

Eligibility

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the department of urology, university hospital of Zurich
Description

biopsy-proven adenocarcinoma of the prostate, to be treated with radical prostatectomy at study site

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C0750484
UMLS CUI [1,3]
C0007112
UMLS CUI [2,1]
C0194810
UMLS CUI [2,2]
C1301732
UMLS CUI [2,3]
C2825164
written informed consent
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic prostate cancer
Description

metastatic prostate cancer

Type de données

boolean

Alias
UMLS CUI [1]
C0936223
contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
Description

contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C2983595
UMLS CUI [2,1]
C0205309
UMLS CUI [2,2]
C0020517
UMLS CUI [2,3]
C0304229
UMLS CUI [3,1]
C0205309
UMLS CUI [3,2]
C0013182
UMLS CUI [3,3]
C0304229
severe heart or lung disease
Description

severe heart or lung disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0024115
UMLS CUI [2,2]
C0205082
severe liver or kidney dysfunction
Description

severe liver or kidney dysfunction

Type de données

boolean

Alias
UMLS CUI [1,1]
C0086565
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0205082
UMLS CUI [2,2]
C3279454
severe stridor
Description

severe stridor

Type de données

boolean

Alias
UMLS CUI [1,1]
C0038450
UMLS CUI [1,2]
C0205082
distant metastases
Description

distant metastases

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0443203
concurrent treatment for other malignant disease
Description

concurrent treatment for other malignant disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0521116
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C0006826
prior hormonal therapy or radiotherapy
Description

prior hormonal therapy or radiotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C1514460
UMLS CUI [2]
C0279134
Retour au début de la page

Similar models

Eligibility

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
biopsy-proven adenocarcinoma of the prostate, to be treated with radical prostatectomy at study site
Item
patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the department of urology, university hospital of Zurich
boolean
C0005558 (UMLS CUI [1,1])
C0750484 (UMLS CUI [1,2])
C0007112 (UMLS CUI [1,3])
C0194810 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C2825164 (UMLS CUI [2,3])
Informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
metastatic prostate cancer
Item
metastatic prostate cancer
boolean
C0936223 (UMLS CUI [1])
contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
Item
contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
boolean
C1301624 (UMLS CUI [1,1])
C2983595 (UMLS CUI [1,2])
C0205309 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
C0304229 (UMLS CUI [2,3])
C0205309 (UMLS CUI [3,1])
C0013182 (UMLS CUI [3,2])
C0304229 (UMLS CUI [3,3])
severe heart or lung disease
Item
severe heart or lung disease
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0024115 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
severe liver or kidney dysfunction
Item
severe liver or kidney dysfunction
boolean
C0086565 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [2,1])
C3279454 (UMLS CUI [2,2])
severe stridor
Item
severe stridor
boolean
C0038450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
distant metastases
Item
distant metastases
boolean
C0027627 (UMLS CUI [1,1])
C0443203 (UMLS CUI [1,2])
concurrent treatment for other malignant disease
Item
concurrent treatment for other malignant disease
boolean
C0521116 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0006826 (UMLS CUI [1,4])
prior hormonal therapy or radiotherapy
Item
prior hormonal therapy or radiotherapy
boolean
C1514460 (UMLS CUI [1])
C0279134 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial